Dr Kathleen Pishas
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
30 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
A scalable, multi-resolution consensus clustering approach for prioritizing robust signals from high-throughput screens
DOI: 10.1093/bib/bbag2422026
Journal article
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on KRAS/NF1 Mutational Status
DOI: 10.3390/ijms270417742026
Journal article
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profile
DOI: 10.1002/path.700752025
Journal article
Assessment of candidate high-grade serous ovarian carcinoma predisposition genes through integrated germline and tumour sequencing
DOI: 10.1038/s41525-024-00447-32024
Journal article
High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma
DOI: 10.1038/s41597-024-03869-x2023
Research grants (international)
Piecing the Puzzle Together: Unravelling the Genomic Landscape of Low Grade Serous Ovarian (LGSOC) Carcinoma to Guide Novel Therapeutic Strategies
2018
Research Grant
Pre-Clinical Evaluation of the Lsd1 Inhibitor Hci-2509: Defining the Biomarkers of Sensitivity and the Mechanisms of Resistance
RECENT SCHOLARLY WORKS
2024
Journal article
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
DOI: 10.1158/1078-0432.CCR-23-35522023
Journal article
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
DOI: 10.1101/2023.11.09.232983212023
Journal article
BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme
DOI: 10.1111/his.149062023
Journal article
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer
DOI: 10.1038/s41588-023-01320-22022
Journal article
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
DOI: 10.1038/s41698-022-00288-2